Earnings ·
The Chemours Company reported second quarter 2026 financial results, posting net sales of $1.6 billion, approximately…
CCChemours Co
The Chemours Company reported second quarter 2026 financial results, posting net sales of $1.6 billion, approximately flat year-over-year. The company recorded a net loss attributable to shareholders of $274 million, or $1.81 per diluted share, compared to a $380 million loss in the prior-year period. Adjusted EBITDA was $247 million, down from $260 million in the previous year, while adjusted net income fell to $64 million from $91 million. Free cash flow improved 128% year-over-year to $114 million, and net leverage declined to 4.4x. The company announced an additional global TiO2 price increase effective June 1, 2026. Chemours operates in the industrial and specialty chemicals industry.